Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release

Probiotics are delivered orally for treating gastrointestinal tract (GIT) infections; thus, they should be protected from the harsh environment of the GIT, such as through microencapsulation. Here, we microencapsulated cells of the probiotic <i>Lacticaseibacillus rhamnosus</i> GG via the...

Full description

Bibliographic Details
Main Authors: Yasir Anwar, Ihsan Ullah, Tahseen Kamal, Muhammad Wajid Ullah
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Biomimetics
Subjects:
Online Access:https://www.mdpi.com/2313-7673/7/4/152
_version_ 1797461299863486464
author Yasir Anwar
Ihsan Ullah
Tahseen Kamal
Muhammad Wajid Ullah
author_facet Yasir Anwar
Ihsan Ullah
Tahseen Kamal
Muhammad Wajid Ullah
author_sort Yasir Anwar
collection DOAJ
description Probiotics are delivered orally for treating gastrointestinal tract (GIT) infections; thus, they should be protected from the harsh environment of the GIT, such as through microencapsulation. Here, we microencapsulated cells of the probiotic <i>Lacticaseibacillus rhamnosus</i> GG via the liquid-droplet-forming method and evaluated them for oral delivery of bovine lactoferrin (bLf). Briefly, sodium alginate capsules (G-capsules) were first prepared, crosslinked with calcium chloride (C-capsules), and then modified with disodium hydrogen phosphate (M-capsules). All capsules showed good swelling behavior in the order of G-capsules > C-capsules > M-capsules in simulated gastric fluid (SGF, pH 2) and simulated intestinal fluid (SIF, pH 7.2). FE-SEM observations showed the formation of porous surfaces and successful microencapsulation of <i>L. rhamnosus</i> GG cells. The microencapsulated probiotics showed 85% and 77% viability in SGF and SIF, respectively, after 300 min. Compared to the 65% and 70% viability of gelation-encapsulated and crosslinking-encapsulated <i>L. rhamnosus</i> GG cells, respectively, the mineralization-encapsulated cells showed up to 85% viability after 300 min in SIF. The entrapment of bLf in the mineralization-encapsulated <i>L. rhamnosus</i> GG cells did not show any toxicity to the cells. FTIR spectroscopy confirmed the successful surface modification of <i>L. rhamnosus</i> GG cells via gelation, crosslinking, and mineralization, along with the entrapment of bLf on the surface of microencapsulated cells. The findings of these studies show that the microencapsulated <i>L. rhamnosus</i> GG cells with natural polyelectrolytes could be used as stable carriers for the oral and sustainable delivery of beneficial biotherapeutics without compromising their viability and the activity of probiotics.
first_indexed 2024-03-09T17:17:21Z
format Article
id doaj.art-7f1fbe6151e54c49831dda725c38cdd0
institution Directory Open Access Journal
issn 2313-7673
language English
last_indexed 2024-03-09T17:17:21Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Biomimetics
spelling doaj.art-7f1fbe6151e54c49831dda725c38cdd02023-11-24T13:30:28ZengMDPI AGBiomimetics2313-76732022-10-017415210.3390/biomimetics7040152Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug ReleaseYasir Anwar0Ihsan Ullah1Tahseen Kamal2Muhammad Wajid Ullah3Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi ArabiaDepartment of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi ArabiaCenter of Excellence for Advanced Materials Research, King Abdulaziz University, Jeddah 21589, Saudi ArabiaBiofuels Institute, School of the Environment and Safety Engineering, Jiangsu University, Zhenjiang 212013, ChinaProbiotics are delivered orally for treating gastrointestinal tract (GIT) infections; thus, they should be protected from the harsh environment of the GIT, such as through microencapsulation. Here, we microencapsulated cells of the probiotic <i>Lacticaseibacillus rhamnosus</i> GG via the liquid-droplet-forming method and evaluated them for oral delivery of bovine lactoferrin (bLf). Briefly, sodium alginate capsules (G-capsules) were first prepared, crosslinked with calcium chloride (C-capsules), and then modified with disodium hydrogen phosphate (M-capsules). All capsules showed good swelling behavior in the order of G-capsules > C-capsules > M-capsules in simulated gastric fluid (SGF, pH 2) and simulated intestinal fluid (SIF, pH 7.2). FE-SEM observations showed the formation of porous surfaces and successful microencapsulation of <i>L. rhamnosus</i> GG cells. The microencapsulated probiotics showed 85% and 77% viability in SGF and SIF, respectively, after 300 min. Compared to the 65% and 70% viability of gelation-encapsulated and crosslinking-encapsulated <i>L. rhamnosus</i> GG cells, respectively, the mineralization-encapsulated cells showed up to 85% viability after 300 min in SIF. The entrapment of bLf in the mineralization-encapsulated <i>L. rhamnosus</i> GG cells did not show any toxicity to the cells. FTIR spectroscopy confirmed the successful surface modification of <i>L. rhamnosus</i> GG cells via gelation, crosslinking, and mineralization, along with the entrapment of bLf on the surface of microencapsulated cells. The findings of these studies show that the microencapsulated <i>L. rhamnosus</i> GG cells with natural polyelectrolytes could be used as stable carriers for the oral and sustainable delivery of beneficial biotherapeutics without compromising their viability and the activity of probiotics.https://www.mdpi.com/2313-7673/7/4/152probioticsmicroencapsulationgelationcrosslinkingmineralizationswelling
spellingShingle Yasir Anwar
Ihsan Ullah
Tahseen Kamal
Muhammad Wajid Ullah
Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release
Biomimetics
probiotics
microencapsulation
gelation
crosslinking
mineralization
swelling
title Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release
title_full Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release
title_fullStr Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release
title_full_unstemmed Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release
title_short Microencapsulation of <i>Lacticaseibacillus rhamnosus</i> GG for Oral Delivery of Bovine Lactoferrin: Study of Encapsulation Stability, Cell Viability, and Drug Release
title_sort microencapsulation of i lacticaseibacillus rhamnosus i gg for oral delivery of bovine lactoferrin study of encapsulation stability cell viability and drug release
topic probiotics
microencapsulation
gelation
crosslinking
mineralization
swelling
url https://www.mdpi.com/2313-7673/7/4/152
work_keys_str_mv AT yasiranwar microencapsulationofilacticaseibacillusrhamnosusiggfororaldeliveryofbovinelactoferrinstudyofencapsulationstabilitycellviabilityanddrugrelease
AT ihsanullah microencapsulationofilacticaseibacillusrhamnosusiggfororaldeliveryofbovinelactoferrinstudyofencapsulationstabilitycellviabilityanddrugrelease
AT tahseenkamal microencapsulationofilacticaseibacillusrhamnosusiggfororaldeliveryofbovinelactoferrinstudyofencapsulationstabilitycellviabilityanddrugrelease
AT muhammadwajidullah microencapsulationofilacticaseibacillusrhamnosusiggfororaldeliveryofbovinelactoferrinstudyofencapsulationstabilitycellviabilityanddrugrelease